Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies arsenic trioxide in treating patients with basal cell
carcinoma. Drugs used in chemotherapy, such as arsenic trioxide, work in different ways to
stop the growth of tumor cells, either by killing the cells or by stop them from dividing